Aug 27, 2026 08:30AM

Aug 27, 2026 08:30AM

Aug 27, 2026 08:30AM

Aug 12, 2026 08:32AM

Aug 12, 2026 08:30AM

Aug 6, 2026 08:31AM

Aug 6, 2026 08:31AM Propanc Biopharma reports preclinical data showing 90% tumor inhibition

Aug 6, 2026 08:30AM

Aug 6, 2026 08:30AM

Jul 7, 2026 08:33AM

Jul 7, 2026 08:30AM

Jun 11, 2026 08:30AM

Jun 11, 2026 08:30AM

Mar 3, 2026 08:46AM Propanc Biopharma reports tumor growth inhibition in preclinical study

Mar 3, 2026 08:45AM

Mar 3, 2026 08:45AM

Feb 5, 2026 08:45AM

Feb 5, 2026 08:45AM

Jan 15, 2026 08:45AM

Jan 15, 2026 08:45AM

Aug 21, 2024 09:00AM Propanc Biopharma’s Peer Reviewed Articles for Proenzymes Cancer Treatment Generates “Unprecedented” Interest

Aug 14, 2024 09:00AM

Jul 17, 2024 09:00AM

Jun 25, 2024 09:00AM

Apr 16, 2024 09:00AM

Feb 22, 2024 08:00AM

Dec 13, 2023 09:00AM

Nov 7, 2023 09:00AM Propanc Biopharma Confirms PRP Enhances Chemosensitivity and Alters Tumor Microenvironment of Pancreatic Tumor Cells

Aug 15, 2023 08:30AM

Jul 13, 2023 08:30AM

Jul 5, 2023 09:00AM

Jun 22, 2023 09:00AM

Mar 28, 2023 09:03AM

Mar 28, 2023 09:00AM

Mar 16, 2023 09:00AM Propanc Biopharma Confirms PRP Exerts Significant Effects Against Chemoresistant Pancreatic Tumor Cells

Dec 15, 2022 09:00AM

Nov 30, 2022 09:00AM

Nov 15, 2022 09:00AM

Oct 26, 2022 09:00AM

Sep 29, 2022 09:00AM

Sep 13, 2022 09:00AM

Sep 8, 2022 09:15AM Propanc Biopharma Reports Significant Effects of PRP Against the Tumor Microenvironment

Aug 16, 2022 09:00AM

Aug 3, 2022 09:00AM

Jul 28, 2022 09:00AM

Jul 12, 2022 09:00AM

Jul 5, 2022 09:00AM

Jun 24, 2022 09:00AM

Jun 24, 2022 09:00AM Propanc Biopharma Announces No Immediate Plans for Reverse Stock Split

Jun 22, 2022 09:00AM

330,193 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All